Banking

Repligen Stock Gets Relative Strength Rating Upgrade With Earnings Due

The Relative Strength (RS) Rating for Repligen (RGEN) headed into a higher percentile Wednesday, as it got a lift from 68 to 73. The company is expected to release its next quarterly numbers on May 4. For more analysis on Repligen stock, check out “Why This IBD Stock Of The Day Is On A Run As Covid Vaccine Demand Surges.”

 




X



When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

This exclusive rating from Investor’s Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock’s price behavior over the last 52 weeks holds up against all the other stocks in our database.

Decades of market research reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves. See if Repligen can continue to rebound and clear that threshold.


Looking For Winning Stocks? Try This Simple Routine


Is Repligen Stock A Buy?

Repligen stock is trying to complete the right side of a consolidation with a 228.94 buy point. See if it can clear the breakout price in heavy trading. That means institutions are stepping in and adding the stock. Read “Looking For The Next Big Stock Market Winners? Start With These 3 Steps” for more tips.

Taking a look at revenue and profit performance, the company has posted rising EPS growth over the last four quarters. Revenue gains have also increased during the same period.

The bioprocessing firm holds the No. 2 rank among its peers in the Medical-Products industry group. Organogenesis (ORGO) and Repligen (RGEN) are also among the group’s highest-rated stocks.

YOU MIGHT ALSO LIKE:

MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button